{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-001321","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.864979+00:00","generated_at":"2026-06-05T23:36:00.277629+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Owens & Minor Q4 adjusted EPS $0.69, revenue $2.66B; full year operating cash flow $741M","bullets":["Q4 GAAP net income $17.8M vs loss of $58.0M; adjusted net income $53.6M vs $21.7M.","Full year adjusted EPS $1.36 vs $2.42; GAAP net loss per share $(0.54) vs $0.29.","Total debt reduced by $403M, net debt reduced by $577M; operating cash flow $741M.","Full year revenue $10.3B, up 4% from $9.96B; Q4 revenue $2.66B vs $2.55B.","Patient Direct segment outperformed; Products & Healthcare Services showed sequential improvement."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-001321","json":"https://secwatch.observer/filing/0001558370-24-001321.json","markdown":"https://secwatch.observer/filing/0001558370-24-001321.md","text":"https://secwatch.observer/filing/0001558370-24-001321.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000155837024001321/0001558370-24-001321-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000155837024001321/tmb-20240220x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T23:36:00.277629+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"26089f518528e6c3de2721794ed65c9cb531e7eb","claim":"ACCENDRA HEALTH INC/VA/ reported the fourth quarter and year ended December 31, 2023 results: revenue $10.3 billion, net income Net loss per common share of $(0.54) and adjusted net income per common share of $1.36.","evidence_excerpt":"& Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023. ​ Full Year 2023 Key Highlights: ● Consolidated revenue of $10.3 billion ● Delivered $741 million of operating cash flow ● Reduced total debt by $403 million and reduced net debt by $577 million ● Net loss per common share of $(0.54) and adjusted net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024001321/0001558370-24-001321-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and year ended December 31, 2023"},{"label":"Revenue","value":"$10.3 billion"},{"label":"Net income","value":"Net loss per common share of $(0.54) and adjusted net income per common share of $1.36"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}